Aggression - 371 Studies Found

Completed : Genetic Load and Phenotype in Aggressive AMD
: Age-related Macular Degeneration
: 2012-07-24
: Device: RetnaGene AMD LDT
Completed : Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance Alone
: Coronary Artery Disease
: 2008-08-27
:
  • Procedure: The aggressive group

Completed : Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
: Coronary Artery Disease
: 2012-03-28
:
  • Drug: standard of care lipid therapy

Completed : R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas
:
  • Diffuse Large B-Cell Lymphoma.
  • Primary Mediastinal B-Cell Lymphoma
  • Procedure: immunotherapy

Completed : Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma
: Non-Hodgkin's Lymphoma
: 2006-10-05
:
  • Drug: Rituximab
  • Drug: DHAP
Completed : Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
:
  • Anaplastic Large Cell Lymphoma
  • Recurrent Adult Burkitt Lymphoma
  • Adult Non-Hodgkin Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Drug: obatoclax mesylate Given
Completed : BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
: Lymphoma, Non-Hodgkin
: 2004-07-28
:
  • Drug: pixantrone, cyclophosphamide, vincristine, rituximab, prednisone

Active, not recruiting : Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL
:
  • Anaplastic Large Cell Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Drug: belinostat Given IV
Terminated : Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)
: Non-Hodgkin's Lymphoma
: 2005-08-22
:
  • Drug: Standard CHOP
  • Drug: Bi-CHOP (dose in
<<< Previous | Next >>>